The European Union is readying a lawsuit against coronavirus maker AstraZeneca for its alleged failure to meet the agreed-upon delivery quota, CNBC reported.
AstraZeneca has failed to deliver the number of coronavirus vaccines it promised to European countries, causing a delayed rollout across the continent, according to CNBC. The European Union’s (EU) executive arm told its 27 member nations Wednesday that it was preparing legal action against the pharmaceutical company over the issues, four unnamed officials told CNBC.
“The commission wants to move fast,” one of the officials said, according to CNBC. “It is a matter of days.”
EU ambassadors largely supported the potential lawsuit, CNBC reported. The officials added that there were just a few legal questions to be reviewed before an action is filed.
“What matters is that we ensure the delivery of a sufficient number of doses in line with the company’s earlier commitments,” an EU spokesperson told CNBC on Thursday.
“Together with the Member States, we are looking at all options to make this happen,” they continued.
The spokesperson wouldn’t confirm or deny the reported lawsuit.
The EU declined to order 100 million more doses of the AstraZeneca vaccine, explaining that it is focusing on first obtaining the doses it has purchased, but which haven’t been delivered, according to U.S. News & World Report. The company has fallen significantly short of promised delivery figures.
“In the first quarter, 30 million doses were delivered, which is less than what was contractually expected. For the second quarter, the contract provided for 180 million doses. The company said it was able to deliver 70 million doses,” EU spokesperson for Health Stefan de Keersmaecker said, U.S. News reported.
Several European countries resumed administering the AstraZeneca vaccine in March after halting vaccinations due to blood clots, according to Science Magazine. Denmark, Iceland, Bulgaria, Luxembourg, Estonia, Lithuania and Latvia were among the nations to stop vaccinations using AstraZeneca doses.
The AstraZeneca vaccine hasn’t yet been granted emergency use authorization in the U.S.
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@dailycallernewsfoundation.org
Americans’ confidence in the economy has dropped to a nearly four-year low, according to a…
Many pundits are predicting that the Democrats will enjoy huge successes in the November mid-term…
Elon Musk’s SpaceX filed to go public in what could become the largest initial public…
Democratic Virginia Gov. Abigail Spanberger is telling her fellow party members it is time to…
The House overwhelmingly passed a housing affordability bill Wednesday that would limit major investors from…
Schedule Summary: President Donald Trump will have executive time, swear-in the new chairman of the…